SUMMARY BK polyomavirus (BKV) causes frequent infections during childhood and
establishes persistent infections within renal tubular cells and the uroepithelium, with …

Despite recent advances in the field of allogeneic hematopoietic stem cell transplantation
(HSCT), viral infections are still a major complication during the period of immune …

It remains difficult to treat the multiplicity of distinct viral infections that afflict
immunocompromised patients. Adoptive transfer of virus-specific T cells (VSTs) can be safe …

Adoptive immunotherapy with transplant donor-derived virus-specific T cells has emerged
as a potentially curative approach for the treatment of drug-refractory EBV+ lymphomas as …

While progress has been made in the treatment of both hematologic cancers and solid
tumors, chemorefractory or relapsed disease often portends a dismal prognosis, and …

Immunotherapy with antigen-specific T cells is a promising, targeted therapeutic option for
patients with cancer as well as for immunocompromised patients with virus infections. In this …

Quantification of BKV-load and BKV-specific immunity have been evaluated to monitor BKV-
replication and outcomes in kidney transplant recipients (KTRs) with BKV-infection …

Objectives Adoptive immunotherapy using donor‐derived antigen‐specific T‐cells can
prevent and treat infection after allogeneic haemopoietic stem cell transplant (HSCT) …

BK polyomavirus is ubiquitous, with a seropositivity rate of over 75% in the adult population.
Primary infection is thought to occur in the respiratory tract, but asymptomatic BK virus …

Adverse outcomes following virus-associated disease in patients receiving allogeneic
haematopoietic stem cell transplantation (HSCT) have encouraged strategies to control viral …